In the high court of South Africa, case no. 4138/98: The global politics of access to low-cost AIDS drugs in poor countries

Kennedy Institute of Ethics Journal

Volumn 12, Issue 2, 2002, Pages 159-174

  Barnard, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DEVELOPING COUNTRY; DRUG INDUSTRY; ECONOMICS; HEALTH CARE AND PUBLIC HEALTH; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEGAL ASPECT; PATENT; SOUTH AFRICA;

HEALTH CARE AND PUBLIC HEALTH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; DEVELOPING COUNTRIES; DRUG INDUSTRY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; PATENTS; PHARMACEUTICAL PREPARATIONS; SOUTH AFRICA;

EID: 0036596307     PISSN: 10546863     EISSN: None     Source Type: Journal    
DOI: 10.1353/ken.2002.0008     Document Type: Article

References (30)

1. Attaran, Amir, and Sachs, Jeffrey. 2001. Defining and Refining International Donor Support for Combating the AIDS Pandemic. Lancet 357: 57-61.
2. Bond, Patrick. 1999. Globalization, Pharmaceutical Pricing, and South African Health Policy: Managing Confrontation with U.S. Firms and Politicians. International Journal of Health Services 29: 765-92.
3. Bradsher, Keith, and Andrews, Edmund. 2001. U.S. Says Bayer Will Cut Cost of Its Anthrax Drug. New York Times (23 October).
4. Brody, Baruch A. 1995. Ethical Issues in Drug Testing, Approval, and Pricing: The Clot- Dissolving Drugs. New York: Oxford University Press.
5. Bureau of the Census [United States]. 1999. World Population Profile 1998. Washington, DC: U.S. Government Printing Office.
6. CDC National Center for HIV, STD and TB Prevention. 2000. Daily News Update (6 September).
7. Correa, Carlos M. 2001. The TRIPS Agreement: How Much Room to Maneuver? Journal of Human Development 2: 79-107.
8. Declaration on the TRIPS Agreement and Public Health. 2001. World Trade Organization, Ministerial Conference, Fourth Session, Doha, Qatar, 9-14 November.
9. Doctors Without Borders. 2000a. Access to Fluconazole in Less Developed Countries [Letter]. Lancet 356: 2102.
10. _. 2000b. HIV/AIDS Medicines Pricing Report: Setting Objectives: Is there a Political Will? Update, December 2000. Available at http://www.accessmed-msf.org/upload/ReportsandPublications/49200113585/ DurbanA%20 report%20dec%202000.pdf. Accessed 15 May 2002.
11. Drèze, Jean, and Sen, Amartya. 1989. Hunger and Public Action. New York: Oxford University Press.
12. Evans, Timothy; Whitehead, Margaret; Diderichsen, Finn; et al., eds. 2001. Challenging Inequities in Health: From Ethics to Action. New York: Oxford University Press.
13. th Annual Meeting, Boston, MA, 15 November.
14. Friedman, Thomas 2001. It Takes a Village. New York Times (27 April).
15. Grant, Alison D., and De Cock, Kevin M. 2001. HIV Infection and AIDS in the Developing World. British Medical Journal 322: 1475-78.
16. Hesie, Lori; Pitanguay, Jacqueline; and Germain, Adrienne. 1993. Violence Against Women: the Hidden Health Burden. World Bank Discussion Paper 255. Washington, DC. Available at http://www.eurowrc.org/06.contributions/ 1.contrib_en/25.contrib.en.htm. Accessed 13 May 2002.
17. International Labor Organization. 2000. HIV/AIDS in Africa: Impact on the World of Work. Paper prepared for the African Development Forum 2000, Addis Ababa, 3-7 December.
18. Kaiser Foundation. 2000. Daily HIV/AIDS Report (5 January; 12 April). Available at http://www.kaisernetwork.org/daily_reports/. Accessed 21 February 2002.
19. LeMonde. 2002. Editorial: France's Cut in Development Aid Is a False Economy. Reprinted in Guardian Weekly (31 January-6 February): 29.
20. Nogués, Julio. 1990. Patents and Pharmaceutical Drugs: Understanding the Pressures on Developing Countries. Journal of World Trade Law 24 (6): 81-104.
21. Pogge, Thomas. 1999. Human Flourishing and Universal Justice. Social Philosophy and Policy 16: 333-61.
22. _. 2001. Eradicating Systemic Poverty: Brief for a Global Resources Dividend. Journal of Human Development 2: 59-77.
23. Reich, Michael R. 2000. The Global Drug Gap. Science 287: 1979-81.
24. South Africa. 2000. Daily Mail and Guardian (31 March). Available at http:// www.mg.co.za/l1.jsp.
25. South Africa Health Review. 2000. Available at http://www.hst.org.za/sahr/2000/. Accessed 13 May 2002.
26. Stolberg, Sheryl G. 2002. AIDS Fund Falls Short of Goal and U.S. Is Given Some Blame. New York Times (13 February).
27. TAC Treatment Access Campaign. 2002. Defiance Campaign: Questions and Answers about TAG and MSF Importing Generic Medicines from Brazil. Available at://www.tac.org.za/Q_A_ImportBrazil.htm. Accessed 13 February 2002.
28. UCSF. 2002. University of California at San Francisco, HIV InSite, www.hivinsite.ucsf.edu. Accessed 21 February 2002.
29. UNAIDS. 2000a. Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infection. South Africa. 2000 Update. Available at http:// www.unaids.org/hivaidsinfo/statistics/fact_sheets/pdfs/Southafrica_en.pdf. Accessed 13 May 2002.
30. _. 2000b. Socioeconomic Impact of HIV/AIDS in Africa. Available at http:// www.unaids.org/publications/documents/economics/agriculture/ADF_slides2.ppt. Accessed 13 May 2002.